Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

Primary immune thrombocytopenia is an autoimmune disorder characterized by increased platelet destruction and insufficient platelet production without another identified underlying disorder. Splenectomy may alter responsiveness to treatment and/or increase the risk of thrombosis, infection, and pulm...

Descripción completa

Detalles Bibliográficos
Autores principales: Cines, Douglas B., Wasser, Jeffrey, Rodeghiero, Francesco, Chong, Beng H., Steurer, Michael, Provan, Drew, Lyons, Roger, Garcia-Chavez, Jaime, Carpenter, Nancy, Wang, Xuena, Eisen, Melissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541869/
https://www.ncbi.nlm.nih.gov/pubmed/28411254
http://dx.doi.org/10.3324/haematol.2016.161968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541869/
https://www.ncbi.nlm.nih.gov/pubmed/28411254
http://dx.doi.org/10.3324/haematol.2016.161968

Ejemplares similares